<?xml version="1.0" encoding="UTF-8"?>
<ref id="B18">
 <label>18</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>McGowan</surname>
    <given-names>J. V.</given-names>
   </name>
   <name>
    <surname>Chung</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Maulik</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Piotrowska</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Walker</surname>
    <given-names>J. M.</given-names>
   </name>
   <name>
    <surname>Yellon</surname>
    <given-names>D. M.</given-names>
   </name>
  </person-group>
  <article-title>Anthracycline chemotherapy and cardiotoxicity</article-title>
  <source>
   <italic toggle="yes">Cardiovascular Drugs and Therapy</italic>
  </source>
  <year>2017</year>
  <volume>31</volume>
  <issue>1</issue>
  <fpage>63</fpage>
  <lpage>75</lpage>
  <pub-id pub-id-type="doi">10.1007/s10557-016-6711-0</pub-id>
  <pub-id pub-id-type="other">2-s2.0-85011903694</pub-id>
  <?supplied-pmid 28185035?>
  <pub-id pub-id-type="pmid">28185035</pub-id>
 </element-citation>
</ref>
